English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 905237 Online Users : 940
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
癌症研究所
蔡慧珍
--會議論文/會議摘要
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
癌症研究所
>
蔡慧珍
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
會議論文/會議摘要
[
14
/17]
期刊論文
[
52
/54]
Siblings
于重元
[
19
/19]
劉柯俊
[
85
/98]
劉滄梧
[
119
/125]
劉界元(2003-2010)
[
3
/3]
夏和雄(1996-2012)
[
26
/31]
夏興國
[
51
/54]
姜乃榕
[
82
/94]
常慧如
[
39
/44]
張俊彥
[
234
/254]
張光裕
[
69
/79]
張憶壽
[
103
/106]
張文祥
[
52
/53]
張書銘
[
89
/91]
彭汪嘉康(1996-2007)
[
120
/126]
施能耀
[
37
/43]
李家惠
[
29
/29]
李岳倫
[
48
/49]
林素芳
[
32
/32]
楊奕馨
[
41
/42]
江士昇
[
88
/90]
沈哲宏
[
14
/16]
洪文俊
[
88
/88]
莊雙恩
[
82
/91]
蔡坤志
[
32
/34]
蘇勇曄
[
40
/40]
蘇振良
[
24
/25]
郭靜娟
[
71
/76]
陳尚鴻
[
45
/48]
陳振陽
[
72
/72]
陳立宗
[
443
/510]
陳美霞(2002-2009)
[
1
/1]
陳詩政
[
2
/2]
陳雅雯
[
38
/39]
黃智興
[
55
/55]
黃道揚
[
26
/26]
丁兆治(2000-2004)
[
5
/5]
其他
[
464
/471]
劉敏(1996-2007)
[
60
/62]
劉玫英(2004-2006)
[
2
/2]
吳成文(1996-2008)
[
53
/55]
曾思文(1997-2007)
[
4
/4]
李冠德(1997-2004)
[
4
/6]
林景太(1999-2007)
[
5
/5]
楊文光(1996-1999)
[
21
/21]
王全正(1996-2003)
[
4
/4]
莊聲宏(1997-2004)
[
11
/11]
詹宗晃(2000-2008)
[
2
/2]
賴基銘(2004-2008)
[
41
/47]
阮麗蓉(2000-2006)
[
6
/7]
陳俊叡(2003-2007)
[
6
/6]
馬彥英(1997-1999)
[
1
/1]
黃奇英(2005-2007)
[
9
/10]
Community Statistics
近3年內發表的文件:12(16.90%)
含全文筆數:66(92.96%)
文件下載次數統計
下載大於0次:66(100.00%)
下載大於100次:62(93.94%)
檔案下載總次數:26987(0.50%)
最後更新時間: 2024-12-01 03:15
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Survival of advanced/recurrent gast...
A phase 1 study of biweekly nab-pac...
Analysis of mutation profiles in ex...
Germline mutations of homologous re...
Risk of type 2 diabetes mellitus an...
Imatinib use for gastrointestinal s...
PTEN regulates invasiveness in panc...
Multi-kinase inhibitors for the tre...
Improved survival with neoadjuvant ...
Mitochondrial phosphoenolpyruvate c...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 26-50 of 71. (3 Page(s) Totally)
<<
<
1
2
3
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2020-11-13
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.]
Scientific Reports. 2020 Nov 13;10:Article number 20199.
2020-07-01
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
Haematologica. 2020 Jul 1;105(7):e349-e354.
2020-05-26
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan
Journal of Biomedical Science. 2020 May 26;27:Article number 69.
2020-05-04
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort
Scientific Reports. 2020 May 4;10:Article number 7420.
2020-05
An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas
Oncologist. 2020 May;25(5):e782-e788.
2019-12
Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia
Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150.
2019-10
The epidemiology of gastric cancers in the era of Helicobacter pylori eradication: A nation-wide cancer registry-based study in Taiwan
Cancer Epidemiology, Biomarkers and Prevention. 2019 Oct;28(10):1694-1703.
2019-09-10
Environmental risk factors of pancreatic cancer
Journal of Clinical Medicine. 2019 Sep 10;8(9):Article number 1427.
2019-04-10
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants
Journal of Medicinal Chemistry. 2019 Apr 10;62(8):3940-3957.
2018-12
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
Cancer Science. 2018 Dec;109(Suppl. 2):866.
2018-12
The epidemiology of gastric cancer in the era of H. pylori eradication: A nation-wide registry-based study in Taiwan
Cancer Science. 2018 Dec;109(Suppl. 2):1437.
2018-11
The incidence and survival of pancreatic cancer by histology, including rare subtypes: A nation-wide cancer registry-based study from Taiwan
Cancer Medicine. 2018 Nov;7(11):5775-5788.
2018-08-24
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
Cancer Science. 2018 Nov;109(11):3591-3601.
2018-08
Stem cell transplantation for T-cell lymphomas in Taiwan
Bone Marrow Transplantation. 2018 Aug;53(8):993-1000.
2018-01
The role of aberrant mitochondrial phosphoenolpyruvate carboxykinase expression in pancreatic neuroendocrine tumors
Cancer Science. 2018 Jan;109(Suppl. 1):466.
2017-10-09
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors
Oncotarget. 2017 Oct 09;8(61):103613-103625.
2017-09-16
The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors
Oncotarget. 2017 Sep 16;8(58):98068-98083.
2017-09
A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients
Scientific Reports. 2017 Sep;7:Article number 11253.
2017-05
A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy
Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531.
2017-02
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)
Journal of Pathology. 2017 Feb;241(3):420-433.
2016-12
Novel cKIT kinase inhibitor, BPRCKJ001, as an advanced therapeutic candidate for GIST
Annals of Oncology. 2016 Dec;27(Suppl. 9):Meeting Abstract 2P.
2016-10
BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia
Molecular Cancer Therapeutics. 2016 Oct;15(10):2323-2333.
2016-10
CagA and NFAT co-operatively participate in the lymphomagenesis of gastric MALT lymphoma
Annals of Oncology. 2016 Oct;27(Suppl. 6):Meeting Abstract 933P.
2016-08-31
The oncometabolite R-2-hydroxyglutarate activates NF-kappa B-dependent tumor-promoting stromal niche for acute myeloid leukemia cells
Scientific Reports. 2016 Aug 31;6:Article number 32428.
2016-05
Efficacy of frontline antibiotics therapy in the treatment of Helicobacter pylori-negative gastric low-grade mucosa-associated lymphoid tissue lymphoma
Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number e19024.
Showing items 26-50 of 71. (3 Page(s) Totally)
<<
<
1
2
3
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback